Tumor Tissues

Tumor tissues refer to tissues composed of cancerous cells, their microenvironment, and supporting stromal and immune cells. They are not a singular molecule, protein, receptor, enzyme, or other well-characterized drug target, but rather the complex cellular and molecular milieu in which tumors arise and progress. Tumor tissues are studied to understand tumor biology, tissue-specific cancer subtypes, and molecular taxonomies of cancer, but are not themselves direct targets for drug therapy. In the biomedical literature, "tumor tissue(s)" describes the cellular and extracellular components of a cancerous lesion, including parenchymal tumor cells and surrounding stromal/immune/inflammatory cells that constitute the tumor microenvironment. There is no canonical biomolecule, gene, protein, receptor, or enzyme universally referred to as "tumor tissues." Rather, tumor tissues encompass many different cell types, molecular features, and biological processes, which can be subclassified based on site of origin, molecular subtype, and microenvironmental characteristics. "Tumor tissues" may serve as a source of molecular biomarkers, and many drug targets are found within them—but the term itself is not a druggable target or structured molecular entity. Therapeutic targeting is directed at specific molecular components within tumor tissues (e.g., receptors like EGFR, enzyme variants, signaling pathways), not at the entire tissue per se. Ultimately, "tumor tissues" is a broad anatomical and pathological descriptor, not a canonical molecular target, and should not be used as a structured entry for drug targeting databases. Instead, drug discovery efforts focus on druggable molecules or pathways within these tissues.

Other names

tumortumor microenvironmentneoplastic tissuecancer tissue